Author(s): CH. Sridevi, Asfiya Azreen, Bathula Shekinah, Bollam Sarika, Boora Priyamsha

Email(s): sridevi.ms18@gmail.com

DOI: 10.52711/0974-360X.2024.00211   

Address: CH. Sridevi*, Asfiya Azreen, Bathula Shekinah, Bollam Sarika, Boora Priyamsha
Department of Pharmacy Practice, Malla Reddy Pharmacy College, Maisammaguda, Dhulapally, Kompally Post, Secunderabad - 500100, Telangana State, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 3,     Year - 2024


ABSTRACT:
The American College of Cardiology (ACC) released guidelines for managing cholesterol in 2018, and procedures for primary and secondary prevention treatment options followed. According to the Collaborative Atorvastatin Diabetes Study (CARDS), a specific population experienced a considerable decline in cardiovascular events. The statistics estimate that statins could add a year to the life expectancy of Coronary Artery Disease (CAD) patients. Objective: The study's primary goals are to identify prescribing trends, the function of statins, and patient responses to questions concerning risk factors and lifestyle choices. Methods: In the cardiology department of a tertiary care hospital, a prospective observational study was carried out for six months. The number of patients enrolled was one hundred fifty. The hospital preceptor carefully checked, vetted and confirmed the data obtained before entering it into a Microsoft Excel spreadsheet for further study. Results: Of the total collected cases, men made up 73.3%, and women comprised 26.6%. The most prescribed statin is Atorvastatin (78.6%). The primary risk factor in Coronary Artery Disease (CAD) is Hypertension (80%), followed by Hyperlipidemia (66.6%) and Diabetes Mellitus (40%), past Coronary Artery Disease (CAD) history (13.3%), thyroid disorders (3.33%). Conclusion: The regularly prescribed statin is Atorvastatin (93%) because of its increased renal safety and cost-effectiveness compared to other statins. Therefore, attention should be paid to following the prescribing patterns of statins. Hypertension is the leading comorbid condition causing Coronary Artery Disease (CAD), followed by Hyperlipidemia, Diabetes Mellitus, patients with a history of CoronaryArtery Disease (CAD), and thyroid disorders (hypothyroidism).


Cite this article:
CH. Sridevi, Asfiya Azreen, Bathula Shekinah, Bollam Sarika, Boora Priyamsha. A Study on Assessment of Risk Factors, Prescribing Patterns, and Role of Statins in Coronary Artery Disease patients. Research Journal of Pharmacy and Technology. 2024; 17(3):1342-5. doi: 10.52711/0974-360X.2024.00211

Cite(Electronic):
CH. Sridevi, Asfiya Azreen, Bathula Shekinah, Bollam Sarika, Boora Priyamsha. A Study on Assessment of Risk Factors, Prescribing Patterns, and Role of Statins in Coronary Artery Disease patients. Research Journal of Pharmacy and Technology. 2024; 17(3):1342-5. doi: 10.52711/0974-360X.2024.00211   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-3-62


REFERENCES:
1.    Ramsaran E, Preusse P, Sundaresan D, et al. Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Managing Patients With Atherosclerotic Cardiovascular Disease. Am J Cardiol 2019; 124(2): 169–175; doi: 10.1016/J.AMJCARD.2019.04.017.
2.    Anonymous. Harrison’s Cardiovascular Medicine Pdf - Libribook. n.d. Available from: https://libribook.com/ebook/14079/harrisons-cardiovascular-medicine-pdf [Last accessed: 1/23/2023].
3.    Wilson PWF. Established Risk Factors and Coronary Artery Disease: The Framingham Study. Am J Hypertens 1994; 7(7_Pt_2): 7S-12S; doi: 10.1093/AJH/7.7.7S.
4.    Anonymous. Roger-Walker-Clinical-Pharmacy-and-Therapeutics-5th-Ed..Pdf - Google Drive. n.d. Available from: https://drive.google.com/file/d/0B8d5-Vl-4ScAOXNMWDVOTXAxODQ/view?resourcekey=0-_t6PinEKGsOkC7kk1Qudpw [Last accessed: 1/23/2023].
5.    Raja S, Mohapatra S, Kumar JS, et al. Prescription Patterns of Hypolipidaemic Drugs in a Tertiary Care Teaching Hospital of Southern India. J Clin Diagn Res. 2014; 8(4): HC01; doi: 10.7860/JCDR/2014/8010.4206.
6.    Lim SY. Role of Statins in Coronary Artery Disease. Ⓒ Chonnam Medical Journal. 2013; 49: 1–6; doi: 10.4068/cmj.2013.49.1.1.
7.    Sadowitz B, Maier KG, Gahtan V. Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease. http://dx.doi.org/101177/1538574410362922 2010;44(4):241–251; doi: 10.1177/1538574410362922.
8.    Vitiello L, Spoletini I, Gorini S, et al. Microvascular inflammation in atherosclerosis. IJC Metab Endocr. 2014; 3: 1–7; doi: 10.1016/j.ijcme.2014.03.002.
9.    Ward NC, Watts GF, Eckel RH. Statin Toxicity: Mechanistic Insights and Clinical Implications. Circ Res. 2019; 124(2): 328–350; doi: 10.1161/CIRCRESAHA.118.312782.
10.    Sekhri T, Kanwar RS, Wilfred R, et al. Prevalence of risk factors for coronary artery disease in an urban Indian population. BMJ Open. 2014; 4: 5346; doi: 10.1136/bmjopen-2014.
11.    Spence JD, Pilote L. Importance of sex and gender in atherosclerosis and cardiovascular disease. Atherosclerosis. 2015; 241(1): 208–210; doi: 10.1016/J.ATHEROSCLEROSIS.2015.04.806.
12.    Nakagawa Y. Role of statins in coronary artery disease. Chonnam Med J. 2013; 49(1): 400–404; doi: 10.4068/CMJ.2013.49.1.1.
13.    Athyros VG, Kakafika AI, Papageorgiou AA, et al. Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. Curr Med Res Opin. 2008; 24(6): 1593–1599; doi: 10.1185/03007990802069563.



Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available